Our latest video covers the basic aspects of alcohol related liver disease, and the complications of excessive alcohol intake. In general, there are three areas of concern: 1. The development of alcoholic fatty liver disease 2. The development of acute alcoholic hepatitis 3. Alcoholic cirrhosis The major point to understanding is that all alcoholic drinks […]
by Dr. Joe Galati on 07/05/2014
by Dr. Joe Galati on 11/29/2013
This past week, the FDA gave approval to Janssen’s new drug to treat hepatitis C. Simeprevir, commercially know as OLYSIO, is the first new hepatitis C drug since the release of telapravir (Incevik) and boceprevir (Victrelis) in 2011. Simeprevir is a NS3/4A protease inhibitor, used in combination with interferon and ribavirin. The release of simeprevir marks […]
by Dr. Joe Galati on 05/15/2013
Our practice, Liver Specialists of Texas and staff, have been supporters of the First Colony Dream League. The Dream League roster is approximately 60 physically- and/or mentally- challenged players. In addition, the league has an “Angels in the Outfield” program, where approximately 150 teenage boys and girls from Ft. Bend area schools volunteer to assist […]
by Dr. Joe Galati on 01/20/2013
Day 20. Hard to believe we are almost finished with the 31 Days of Wellness. Don’t fear, there are 334 days in the year left afterwards. There is a very nice entry from the New York Times Recipe for Health section, that features an assortment of healthful recipes you should all bookmark and check in […]
by Dr. Joe Galati on 09/18/2012
by Dr. Joe Galati on 08/11/2012
We have produced a brief introductory video describing the staff and activities of Liver Specialists of Texas. Let us know what you think. Your feedback is valued.
by Dr. Joe Galati on 05/15/2011
Now that Boceprevir is FDA approved, it seems that a big sigh of relief has been let out by both patients and physicians. Despite this great news and FDA success, the work now starts, evaluating and screening the thousands of patients that have been waiting for this day. Here is my advice to all concerned […]
by Dr. Joe Galati on 02/28/2011
For those of us that are involved in the care of patients with chronic hepatitis C, the “never too soon” announcement that we will finally have new drugs to treat our hepatitis C patients with cannot come soon enough. There is a real possibility that one and possibly two new agents for hepatitis C will […]
by Dr. Joe Galati on 02/02/2011
Patients awaiting transplant commonly have questions regarding there MELD score, and how this number is determined. As you can imagine, there is great anxiety in patients awaiting transplant. At almost every clinic visit, patients are asking for they’re updated score. In my own practice, at every visit we calculate the new score and discussed this result with […]
- Telaprevir and FDA Approval: The Race is On for New Hepatitis C Drugs 02/28/2011
- The MELD Score and Liver Transplant: An Update for Patients 02/02/2011
- Waiting for a Liver Transplant: My MELD Score is Low-Now What? 06/14/2012
- Grazoprevir and Elbasvir: New Hepatitis C Treatment Options with High Cure Rates 11/11/2014
- Liver Transplant with Donors Over 80 Years Old Do Well 11/09/2014
- Olysio and Sovaldi Now Approved for Hepatitis C 11/07/2014
- Chuck Garcia: On a recent stroll through the supermarket aisles,...
- K Beecher: Hello. My husband was 24 to 48 hours away from dy...
- Firdous Ahmad: Dear Dr, My mother have hepatitis C, and she also ...